Viral Hepatitis A, B & C: Surveillance, Prevention & Control
Last Updated on January 25, 2020 by HepFree NYC
Related Articles
-
Report Medicaid Managed Care Pharmacy & Medication ‘Issues’ to NYS DOH Pharmacy Program
Report Medicaid Managed Care Pharmacy & Medication ‘Issues’ to NYS DOH Pharmacy Program by describing the issue in detail in an email to: PPNO@Health.state.ny.US. Medical Providers, Patient Navigators, Case Managers, Care Managers, Advocates, Pharmacists, Patients...
-
Media Advisory | Hep Awareness Month Press Conference 2013
Elected officials, community leaders and public health officials will announce free and low cost hepatitis screenings and unveil a new PSA campaign in New York City, San Francisco and Los Angeles.
-
Team HBV NYC
There are numerous opportunities available for students to assist NYC Hepatitis B Coalition member organizations through internships and volunteer projects.
-
News | HCMSG’s New Hep C Educational Tool
Hep C Mentor and Support Group (HCMSG) developed a virtual training that provides a free overview of Hep C Basics and HCMSG’s Circle Model.
-
Press Release | 2016 World Hepatitis Day (Hep Free NYC)
World Hepatitis Day provides a platform for people to speak out, be engaged and take action to ensure global commitments are met and viral hepatitis is eliminated by 2030.
-
FDA Approves Daklinza/Sovaldi to Treat Hep C Genotype 1
FDA Expands Daklinza/Sovaldi Approval to Include Treatment of Hep C Genotype 1
-
Job | Hep B Public Health Advisor @ NYC Health Dept
Public Health Advisor II – Immunization Surveillance Unit Bureau of Immunization Apply Now Job ID: 591097 Location: 42-09 28th Street Full/Part-time: Full-Time Salary Range: $51,528.00 – $63,997.00 Job Description: Established in 1805, the New York City Department of He...
-
Un réseau d’organisations pour l’augmentation de nos capacités de prévenir, gérer et traiter les hépatites B et C à New York City
To build community and provider partnerships for prevention, raise awareness, provide screening, immunization and referral services, and reduce cultural and language barriers for treatment for liver diseases for African immigrants and refugees.
